Media
Corgentech to Present at NewsMakers in the Biotech Industry Conference
SOUTH SAN FRANCISCO, Calif., Sep 2, 2004 (BUSINESS WIRE) -- Corgentech Inc. (NASDAQ:CGTK), a biotechnology company, today announced that John McLaughlin, the company's president and chief executive officer, will present at NewsMakers in the Biotech Industry Conference on Thursday September 9, 2004 at 10:30 a.m. EDT at the Millennium Broadway Hotel in New York. The live and archived webcast of this presentation can be accessed by logging onto Corgentech's web site at www.corgentech.com and going to the Investor Information page.
The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
About Corgentech
Corgentech is a biopharmaceutical company engaged in the discovery, development and commercialization of a new class of therapeutics called transcription factor decoys, or TF decoys. We are creating a pipeline of novel therapeutics based on our proprietary TF decoy technology, focused initially on the treatment of cardiovascular disease, inflammatory disease, such as arthritis and dermatitis, and cancer. For more information on the company and its technology, visit www.corgentech.com.
SOURCE: Corgentech
Corgentech Inc. Richard Powers, 650-624-9600 [email protected] or WeissComm Partners Daryl Messinger, 415-999-2361 [email protected]
Customize your Business Wire news & multimedia to match your needs. Get breaking news from companies and organizations worldwide. Logon for FREE today at www.BusinessWire.com.
Copyright (C) 2004 Business Wire. All rights reserved.
News Provided by COMTEX
